Wisconsin Fines Vape Retailers Nearly $13 Million for Selling Unapproved Products

Dec.11.2025
The state of Wisconsin has fined one retailer nearly USD 12.44 million and another USD 450,000 for violating the state’s new vape sales law, which took effect in September and restricts sales to an approved list of products.

Key Point

 

  • Regulatory body: Wisconsin Department of Revenue (DOR)
  • Retailers fined: Exclusive Tobacco; Dave’z Smoke N Vape LLC
  • Fines: ~USD 12.44 million and USD 450,000
  • Violations: Sale of unapproved vape products; expired municipal licenses
  • Law effective: September 1, 2024 (based on 2023 legislation)
  • Appeal status: Hearing scheduled Dec. 10 before the U.S. 7th Circuit Court of Appeals

 


 

2Firsts, December 11, 2025 – According to the Milwaukee Journal Sentinel, Wisconsin has imposed fines totaling nearly USD 13 million on two vape retailers for violating the state’s new vape law, which restricts sales to an approved product directory.

 

Exclusive Tobacco, a four-store chain with a location in Oshkosh, was fined USD 1,000 per unapproved vape device, totaling USD 1,244,000 for 1,244 illegal vapes. Because the company failed to comply within 10 days of a warning, the fine was multiplied tenfold, reaching over USD 12.4 million.

 

The Department of Revenue (DOR) later received another complaint indicating continued illegal sales, leading to a second inspection and a USD 431,000 fine. DOR spokeswoman Jennifer Bacon confirmed that Exclusive Tobacco is appealing both penalties.

 

A second retailer, Dave’z Smoke N Vape LLC in Green Bay, was fined USD 450,000 for selling without a municipal license.

 

Since the law took effect on September 1, 2024, the DOR has issued 42 product removal orders and conducted 27 seizures statewide, including two involving unlicensed operations.

 

Wisconsin Fines Vape Retailers Nearly $13 Million for Selling Unapproved Products
Xtreme Vape, formerly at 2242 Neva Road in Antigo, closed because of the new vape law, owner George Packard says. A “space for rent” sign is displayed at the premises on Oct. 11.|HOPE KARNOPP / MILWAUKEE JOURNAL SENTINEL

 

Initially, enforcement focused on compliance education, but the department is now strictly applying the 2023 law’s procedures. The fines are based on the sale of products not listed among 303 approved vape types, which include brands such as Juul, Blu, Vuse, and Crossbar.

 

Meanwhile, the industry group Wisconsinites for Alternatives to Smoking and Tobacco (WiscoFAST) has appealed the law, arguing it favors large tobacco companies. The U.S. 7th Circuit Court of Appeals in Chicago is scheduled to hear oral arguments on December 10, with a ruling expected in late January.

 

Public health advocates are divided on the law’s impact. Some question whether removing select products while leaving others available can effectively protect youth. State officials defend it as a “measured approach” to balance public safety and regulatory control.

 

Cover image: Screenshot from the video “Milwaukee smoke shop owners react to Wisconsin’s new vape law”
Source: Milwaukee Journal Sentinel

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Opinion | As EU Reviews Tobacco Rules, Experts Warn Against Overlooking Smokers’ Alternatives
Opinion | As EU Reviews Tobacco Rules, Experts Warn Against Overlooking Smokers’ Alternatives
As the European Commission reviews its tobacco and advertising rules, two experts who provided written comments to 2Firsts argue that future EU policy should not overlook adult smokers’ alternatives. Dr Garrett McGovern and Dr Carmen Escrig say regulators should weigh relative risk, adult switching, flavours, consumer behaviour and scientific uncertainty alongside youth protection.
Industry Insight
Jun.01
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
Bringing Tax and Insurance Into Nicotine Regulation: Insights From a Tobacco Harm-Reduction Report
A smoke-free nicotine policy report argues that tobacco harm reduction should move beyond product bans and health warnings into tax policy, insurance pricing and risk-based regulation. While some projections remain open to debate, the report highlights a wider challenge: nicotine products, technologies and consumer behavior have changed sharply over the past decade, and regulatory systems may need new tools to better align tobacco control with harm-reduction goals.
Jun.08
EU Launches Online Feedback as TPD Revision Enters New Milestone
EU Launches Online Feedback as TPD Revision Enters New Milestone
The European Commission has opened an online call for evidence on revising EU tobacco products and advertising rules, marking a new phase in the TPD/TAD review. Policy options may cover novel products, flavours, packaging, digital marketing and advertising. A 2Firsts review of 855 early submissions shows rapid engagement and recurring debate over differentiated regulation, harm reduction, youth protection, illicit trade and economic impact.
Special Report
May.21
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13